NCT02249741View on ClinicalTrials.gov

Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation

PHASE4CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Cirrhosis
Interventions
DRUG

Treated with Ibandronic acid as per protocol

treated with Ibandronic acid at a dose of 150 mg once a month for six months

Trial Locations (1)

110060

Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, New Delhi

All Listed Sponsors
lead

Dr. Ashish Kumar

OTHER

NCT02249741 - Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation | Biotech Hunter | Biotech Hunter